Cargando…
The World Health Organization Prequalification Program and Clinical Pharmacology in 2030
Autores principales: | Blaschke, Terrence F., Lumpkin, Murray, Hartman, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586841/ https://www.ncbi.nlm.nih.gov/pubmed/31773722 http://dx.doi.org/10.1002/cpt.1680 |
Ejemplares similares
-
The Manufacturers’ Perspective on World Health Organization Prequalification of In Vitro Diagnostics
por: Morin, Sébastien, et al.
Publicado: (2018) -
A survey of nongovernmental organizations on their use of WHO’s prequalification programme
por: Giralt, Ariadna Nebot, et al.
Publicado: (2020) -
Implementing interprofessional bedside rounding at the prequalification stage
por: Tuite, Daniel R, et al.
Publicado: (2016) -
Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics
por: Arlett, Peter, et al.
Publicado: (2019) -
Treatment of the hypertensive patient in 2030
por: Bhudia, Roshni P.
Publicado: (2020)